Alcon AG (ALC)vsNephros Inc (NEPH)
ALC
Alcon AG
$66.81
+0.35%
HEALTHCARE · Cap: $33.11B
NEPH
Nephros Inc
$3.42
-4.74%
HEALTHCARE · Cap: $36.80M
Smart Verdict
WallStSmart Research — data-driven comparison
Alcon AG generates 55506% more annual revenue ($10.63B vs $19.12M). ALC leads profitability with a 7.7% profit margin vs 4.1%. ALC trades at a lower P/E of 40.7x. ALC earns a higher WallStSmart Score of 49/100 (D+).
ALC
Hold49
out of 100
Grade: D+
NEPH
Avoid32
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-24.0%
Fair Value
$64.04
Current Price
$66.81
$2.77 premium
Margin of Safety
+6.9%
Fair Value
$4.34
Current Price
$3.42
$0.92 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
ROE of 3.7% — below average capital efficiency
7.7% margin — thin
Weak financial health signals
Smaller company, higher risk/reward
ROE of 7.3% — below average capital efficiency
4.1% margin — thin
Operating margin of 1.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : ALC
The strongest argument for ALC centers on Price/Book, Debt/Equity.
Bull Case : NEPH
The strongest argument for NEPH centers on Debt/Equity.
Bear Case : ALC
The primary concerns for ALC are PEG Ratio, Return on Equity, Profit Margin. A P/E of 40.7x leaves little room for execution misses.
Bear Case : NEPH
The primary concerns for NEPH are Market Cap, Return on Equity, Profit Margin. A P/E of 48.4x leaves little room for execution misses. Thin 4.1% margins leave little buffer for downturns.
Key Dynamics to Monitor
NEPH carries more volatility with a beta of 1.50 — expect wider price swings.
ALC is growing revenue faster at 9.4% — sustainability is the question.
ALC generates stronger free cash flow (274M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ALC scores higher overall (49/100 vs 32/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Alcon AG
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Visit Website →Nephros Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?